Literature DB >> 8128048

Malignant vascular tumors of the liver: radiologic-pathologic correlation.

P C Buetow1, J L Buck, P R Ros, Z D Goodman.   

Abstract

Although benign vascular tumors of the liver are extremely common (hemangioma is the most common), malignant vascular tumors of the liver are very rare. In the adult, these tumors are angiosarcoma, epithelioid hemangioendothelioma, and Kaposi sarcoma. All hepatic malignant vascular tumors share histologic characteristics, grow around and into vessels, and are grossly multifocal. They may be misdiagnosed histologically, particularly if only a biopsy sample is available. Although imaging findings are often non-specific, some features are suggestive or even characteristic of these neoplasms. Such features include previous exposure to thorium dioxide (Thorotrast) in cases of angiosarcoma, coalescence of multiple nodules into large peripheral masses in epithelioid hemangioendothelioma, and association between acquired immunodeficiency syndrome and cutaneous involvement in Kaposi sarcoma. Because hepatic malignant vascular tumors are often multiple, the main differential diagnosis is metastatic disease. There is no effective treatment for these tumors, and although survival time is variable, the prognosis is generally unfavorable.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8128048     DOI: 10.1148/radiographics.14.1.8128048

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  25 in total

1.  Metastasis of hepatic angiosarcoma to the stomach.

Authors:  Tae-Oh Kim; Gwang-Ha Kim; Jeong Heo; Dae-Hwan Kang; Geun-Am Song; Mong Cho
Journal:  J Gastroenterol       Date:  2005-10       Impact factor: 7.527

2.  Contrast-enhanced multiple-phase imaging features in hepatic epithelioid hemangioendothelioma.

Authors:  Ying Chen; Ri-Sheng Yu; Ling-Ling Qiu; Ding-Yao Jiang; Yan-Bin Tan; Yan-Biao Fu
Journal:  World J Gastroenterol       Date:  2011-08-14       Impact factor: 5.742

3.  Differentiating primary hepatic angiosarcomas from hemangiomatosis and epithelioid hemangioendotheliomas using gadoxetic acid-enhanced and diffusion-weighted MR imaging.

Authors:  Jung Wook Seo; Seong Hyun Kim; Ah Yeong Kim; Woo Kyoung Jeong; Ji Young Woo; Won Jeong Park
Journal:  Jpn J Radiol       Date:  2017-09-06       Impact factor: 2.374

Review 4.  Angiosarcoma: clinical and imaging features from head to toe.

Authors:  Ayman H Gaballah; Corey T Jensen; Sarah Palmquist; Perry J Pickhardt; Alper Duran; Gregory Broering; Khaled M Elsayes
Journal:  Br J Radiol       Date:  2017-05-04       Impact factor: 3.039

5.  Primary hepatic angiosarcoma: multi-institutional comprehensive cancer centre review of multiphasic CT and MR imaging in 35 patients.

Authors:  Perry J Pickhardt; Douglas Kitchin; Meghan G Lubner; Dhakshina M Ganeshan; Sanjeev Bhalla; Anne M Covey
Journal:  Eur Radiol       Date:  2014-10-04       Impact factor: 5.315

6.  Contrast-enhanced ultrasound in diagnosis of primary hepatic angiosarcoma.

Authors:  Wenwu Ling; Tingting Qiu; Lin Ma; Chuanfen Lei; Yan Luo
Journal:  J Med Ultrason (2001)       Date:  2016-12-01       Impact factor: 1.314

7.  Statistics and outlook of primary hepatic angiosarcoma based on clinical stage.

Authors:  I-Hsuan Huang; Yi-Ying Wu; Tzu-Chuan Huang; Wei-Kuo Chang; Jia-Hong Chen
Journal:  Oncol Lett       Date:  2016-03-17       Impact factor: 2.967

8.  Clinical manifestations of primary hepatic angiosarcoma.

Authors:  Enrique Molina; Alfredo Hernandez
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

9.  Hepatic angiosarcoma manifested as recurrent hemoperitoneum.

Authors:  Seung-Woo Lee; Chun-Young Song; Young-Hwa Gi; Sang-Beom Kang; Yon-Soo Kim; Soon-Woo Nam; Dong-Soo Lee; Jong-Ok Kim
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

10.  Solitary small hepatic angiosarcoma: initial and follow-up imaging findings.

Authors:  Suk Hee Heo; Yong Yeon Jeong; Sang Soo Shin; Tae Woong Chung; Heoung Keun Kang
Journal:  Korean J Radiol       Date:  2007 Mar-Apr       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.